Molgendiasp. z o.o.

Other professional, scientific and technical activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2011-09-12
Share capital
10,000.00 PLN
Activity description

Molgendia supplies laboratory reagents and equipment for molecular oncology and hemato-oncology, along with CatchGene kits for isolating DNA and RNA from biological samples. It offers Belgian and Dutch molecular profiles, including OncoDNA tests based on NGS sequencing and immunohistochemistry to support cancer treatment selection and monitoring.

Registered address
ul. Fordońska 246, 85-766 Bydgoszcz, Poland
Opening hours
Monday–Friday
8:00–16:00
Phone
Social media
Electronic delivery address
AE:PL-35451-96447-AESFS-20

Financials

Revenue history (in k)

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 264 days for 2020).

  • 202527/07/2026
  • 202415/07/2025
  • 202313/07/2024
  • 202211/08/2023
  • 202130/11/2022
  • 202006/07/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 276.20kMedianUSD 70.54kAverageUSD 519.25k
Net profit
This companyUSD -32.30kMedianUSD 2.53kAverageUSD 5.54k
Operating costs
This companyUSD 305.78kMedianUSD 57.18kAverageUSD 450.21k
Assets
This companyUSD 473.04kMedianUSD 61.01kAverageUSD 1.39m

Offer

  • DNA isolation kits
  • RNA isolation kits
  • Nucleic acid purification system
  • Liquid biopsy reagents

Website technology

Website
  • WordPress
Contact and booking
  • tawk.to

Public procurement

10 tenders recorded as contractor: 3 national ($76,494) and 7 EU ($337,437).

SubjectAmount
DFP.271.107.2026.AB - Supply of reagents, consumables and control materials together with the lease of an analyser, and supply of reagents, consumables and control materials.
$15,845
Supply of reagents and auxiliary materials used in diagnostics for the Cytogenetics Laboratory and lease of an IHC system for Zakład Patomorfologii at USK Nr 1 PUM
$6,944
Supply of reagents with lease of a system for assessing molecular variants in solid tumors and hemato-oncology
$19,074

Authorized Representatives

Remigiusz Jan Lewandowski – President of the Management Board & Attorney-in-fact (sole)

Manner of representation

If the management board is a one-person management board, each member of the management board is authorized to submit declarations of will on behalf of the company independently. If the management board is a multi-member management board, joint action by two members of the management board is required to submit declarations of will on behalf of the company.

Ownership

OwnerSharesShare valueStake
Remigiusz Jan Lewandowskiage 48
95$2,566.1895%
Others
5$135.065%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2011-10-12.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

7 public aid cases recorded, with a total value of $41,923.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$15,524
Other crisis aid
$3,587
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$18,462

Competitors

Name
Genhelpsp. z o.o.
Nuclear Plsp. z o.o.
Custom Energysp. z o.o.
Ventiair Innovationssp. z o.o.
Biovastum Techsp. z o.o.
Blueshiftsp. z o.o.
Jbbr Strategy & Innovationsp. z o.o.
Centauronsp. z o.o.
Hornet Design Studio Boniśniaksp. j.
BIT - Systemsp. z o.o.

Change history

DateEvent
2023-08-03Address change
2015-10-27Address change
2015-10-27PKD change
2011-09-12Entered in the register

FAQ

Last updated: 2026-07-27